SEC Form 4 Filing for Pierre Sargis

Pierre Sargis, Chief Medical Officer of FENNEC PHARMACEUTICALS INC., reported a transaction on July 31, 2026. The filing indicates the acquisition of 168 shares of common stock, with the price per share being $0.00. This transaction resulted in a post-transaction share count of 21,351. The shares were released from restriction, originally awarded on March 28, 2025. This is a direct ownership transaction.